Phathom PharmaceuticalsPHAT
那斯達克 · USD
10.71
+0.34
(+3.28%)
收盤 06/16 03:59 (UTC+8)
06/16 03:59 (UTC+8)
Phathom PharmaceuticalsPHAT
10.71
+0.34
(+3.28%)
財務數據
損益表
- 0.01
- 0.02
- 0.07
- 0.16
- 0.30
- 0.29
- 0.40
- 0.50
- 0.58
- 0.58
- -
- 180.35
- 283.05
- 123.27
- 81.41
- -3.86
- 38.52
- 25.31
- 16.32
- 1.25
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | |
營業收入淨額 | 58,301 | 57,584 | 49,503 | 39,504 | 28,519 | 29,664 | 16,352 | 7,324 | 1,912 | 682 |
營業成本 | 11,996 | 7,648 | 6,189 | 5,038 | 3,724 | 3,815 | 2,356 | 1,376 | 426 | 167 |
營業毛利 | 46,305 | 49,936 | 43,314 | 34,466 | 24,795 | 25,849 | 13,996 | 5,948 | 1,486 | 515 |
營業費用 | 61,782 | 55,864 | 58,586 | 94,389 | 103,658 | - | - | - | 71,440 | 70,390 |
研發費用 | 7,771 | 7,493 | 7,027 | 9,076 | 9,184 | 8,583 | 8,693 | 7,376 | 9,430 | 13,394 |
推銷及管理費用 | 54,011 | 48,371 | 51,559 | 85,313 | 94,474 | 76,683 | 76,099 | 75,872 | 62,010 | 56,996 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -15,477 | -5,928 | -15,272 | -59,923 | -78,863 | -59,417 | -70,796 | -77,300 | -69,954 | -69,875 |
其他收入及費用 | 905 | 1,199 | 1,407 | 1,630 | 2,618 | 3,559 | 3,703 | 3,618 | 4,270 | 3,334 |
利息費用 | 15,797 | 16,419 | 16,108 | 17,517 | 18,071 | 18,593 | 18,484 | 17,764 | 17,168 | 13,029 |
稅前純益 | -30,369 | -21,148 | -29,973 | -75,810 | -94,316 | -74,451 | -85,577 | -91,446 | -82,852 | -79,570 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -30,369 | -21,148 | -29,973 | -75,810 | -94,316 | -74,451 | -85,577 | -91,446 | -82,852 | -79,570 |
基本每股稅後盈餘(元) | -0.37 | -0.29 | -0.41 | -1.05 | -1.31 | -1.05 | -1.32 | -1.56 | -1.42 | - |
稀釋每股稅後盈餘(元) | -0.37 | -0.27 | -0.41 | -1.05 | -1.31 | -1.00 | -1.31 | -1.56 | -1.42 | -1.45 |
基本平均股數(千股) | 82050.00 | 73817.00 | 73396.00 | 72466.00 | 71969.00 | 71044.00 | 64627.00 | 58558.00 | 58371.00 | - |
稀釋平均股數(千股) | 82050.00 | 73817.00 | 73396.00 | 72466.00 | 71969.00 | 71044.00 | 64627.00 | 58558.00 | 58371.00 | - |
還原基本每股稅後盈餘(元) | -0.37 | -0.29 | -0.41 | -1.05 | -1.31 | -1.05 | -1.32 | -1.56 | -1.42 | - |
還原稀釋每股稅後盈餘(元) | -0.37 | -0.27 | -0.41 | -1.05 | -1.31 | -1.00 | -1.31 | -1.56 | -1.42 | -1.45 |
還原基本平均股數(千股) | 82,050 | 73,817 | 73,396 | 72,466 | 71,969 | 71,044 | 64,627 | 58,558 | 58,371 | - |
還原稀釋平均股數(千股) | 82,050 | 73,817 | 73,396 | 72,466 | 71,969 | 71,044 | 64,627 | 58,558 | 58,371 | - |
EBITDA(千元) | -13,618 | -3,792 | -12,934 | -57,387 | -75,372 | -55,036 | -66,313 | -72,985 | -64,996 | -65,790 |